Patients Stopping Slimming Jabs Put On Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who halt conventional diet and exercise plans.

Research printed in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month once they quit.

"Users buying such treatments need to be informed of the danger of quick rebound weight gain when the medication concludes," warns researcher Dr. Susan Jebb.

This pace of regain suggests a return to starting weight in about 18 months.

Weighing Treatments

The research, which examined dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with other pills.

The team emphasize that individuals who lose weight through diet and exercise usually see a less rapid weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Fast Rebound

Experts propose the way of the injections is key to understanding the heightened rebound.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates hunger.

"Long-term administration of GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication leads to hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Condition?

Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Professionals contend that, given the high risk of relapse, the treatment should be considered ongoing.

This view is echoed by drug manufacturers, who note that the findings "underscore the chronic character of obesity," comparing it to managing conditions like diabetes.

User Testimonies

People who have come off the medication explain a intense resurgence of appetite.

"It felt as if a switch flipping and you become starving," described one woman.

This difficulty is worsened if individuals have not adopted sustainable lifestyle or habit changes during therapy.

Significant Use

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among females than men.
• The 40s and 50s demographic shows the highest usage rates.
• Many obtain the drugs through private prescriptions rather than the NHS.

Finally, clinicians stress that while the jabs are effective tools for weight loss, they are not a standalone fix and maintained weight loss hinges on integrated behavioural management.